This segment focuses on developing and providing clinical chemistry and immunoassay instruments and tests. Research and development efforts are centered on creating automated systems and assays for detecting and monitoring disease progression across various therapeutic areas, including infectious diseases like COVID-19. Technologies employed include advanced analytical techniques and automated platforms to ensure accuracy and efficiency. The segment's impact is significant, enabling timely and accurate diagnoses, which directly influences patient outcomes. Market positioning is strong due to the company's established presence and innovative solutions. Future opportunities lie in expanding the test menu and integrating advanced technologies like AI for improved diagnostics. Regulatory compliance and clinical validation are critical aspects, with products requiring FDA approval and adherence to stringent quality standards. Partnerships with healthcare providers and laboratories are essential for market access and distribution.

The Immunohematology segment is dedicated to providing instruments and tests for blood typing and screening. Research and development activities focus on improving the accuracy and efficiency of blood typing to ensure patient-donor compatibility in blood transfusions. This includes developing advanced instruments and tests for donor screening to detect infectious diseases in blood and plasma. Technologies used include automated systems and sophisticated assays. The segment's impact is critical in ensuring patient safety during blood transfusions and in maintaining a safe blood supply. Ortho Clinical Diagnostics holds a strong market position in this area due to its established reputation and innovative solutions. Future opportunities include expanding the test menu and integrating advanced technologies. Regulatory compliance and clinical validation are paramount, with products requiring FDA approval and adherence to strict quality standards. Partnerships with blood banks and transfusion centers are essential for market access and distribution.